2617 Global Intellectual Property Due Diligence
2620 A Marriage of Convenience? Big Pharma and Venture Capital
2650 For Better or Worse, For Richer or Poorer: Partners Who Will Go The Distance
2674 M&A for U.S. Biotech: Think Outside the Box
2722 Deal-Making with Japanese Pharmaceutical Companies
2907 Alliance Managment's Role in Building Partner-centric Organizations: Recipe for Successful Alliances
3015 Biotech M&A - How to Sell Your Company in an Environment of Consolidation
3064 Balancing the Equation in Leading Deals: Cherry Picking Value or a Sustainable Course?
3147 Maximising Value: How Tough Markets Are Reshaping the Business Models of Big Pharma and Venture Capital
3182 Effectively Managing Multiple Deals Across A Technology Platform
3191 Business Model Conundrum: Focus on One Single Therapeutic Area, or Multiple Areas?
3196 Different Type of Partnerships Which Compose PDPs for Improved Global Health
3988 Out or In, Big or Small: Industry and Venture-backed Out Licensing Deals and New Companies — What Are We Looking For?